Evidence map›Paper›PMID 32835181›Full record

ReviewBioresource technology reports2020

Emerging priorities for microbial metagenome research.

Rangasamy Kirubakaran, K N ArulJothi, Sundaravadivel Revathi, Nowsheen Shameem, Javid A Parray

Open access · greenAbstract readReview
In one paragraph

Review in Bioresource technology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Molecular advances in microbial α-galactosidases: challenges and prospects.World journal of microbiology & biotechnology · 2022
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Rangasamy KirubakaranDepartment of Biotechnology, Vysya College, Salem, Tamil Nadu, India.
K N ArulJothiDepartment of Genetic Engineering, SRM Institute of Science and Technology, Chennai, India.
Sundaravadivel RevathiDepartment of Biochemistry, Vysya College, Salem, Tamil Nadu, India.
Nowsheen ShameemDepartment of Environmental Science, Cluster University Srinagar, J&K, India.
Javid A ParrayDepartment of Environmental Science, Govt SAM Degree College Budgam, J&K, India.
Cluster University Srinagar · INUniversity of Cape Town · ZAVinayaka Missions Medical College and Hospitals · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Overwhelming anthropogenic activities lead to deterioration of natural resources and the environment. The microorganisms are considered desirable, due to their suitability for easy genetic manipulation and handling. With the aid of modern biotechnological techniques, the culturable microorganisms have been widely exploited for the benefit of mankind. Metagenomics, a powerful tool to access the abundant biodiversity of the environmental samples including the unculturable microbes, to determine microbial diversity and population structure, their ecological roles and expose novel genes of interest. This review focuses on the microbial adaptations to the adverse environmental conditions, metagenomic techniques employed towards microbial biotechnology. Metagenomic approach helps to understand microbial ecology and to identify useful microbial derivatives like antibiotics, toxins, and enzymes with diverse and enhanced function. It also summarizes the application of metagenomics in clinical diagnosis, improving microbial ecology, therapeutics, xenobiotic degradation and impact on agricultural crops.

Indexed as

BioremediationBiotechnological applicationEnvironmentMetagenomeXenobiotics

Identifiers

PMID32835181
PMCPMC7319936
OpenAlexW3037883442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.